Argon versus Selective Laser Trabeculoplasty

Journal of Glaucoma

Volumn 13, Issue 2, 2004, Pages 174-177

  Cioffi, George A ^a   Latina, Mark A ^b   Schwartz, Gail F ^c  

^a DEVERS EYE INSTITUTE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARGON LASER; ARTICLE; CASE REPORT; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; MALE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; TRABECULOPLASTY; TREATMENT INDICATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTIHYPERTENSIVE AGENTS; ARGON; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; MALE; OPTIC NERVE DISEASES; TRABECULECTOMY; VISUAL ACUITY; VISUAL FIELDS;

EID: 1642276402     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200404000-00016     Document Type: Article

References (4)

1. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology. 1990;97:1403-1413.
2. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7-year results. Am J Ophthalmol. 1995;120:718-731.
3. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results. Ophthalmology. 1998;105:1146-1164.
4. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001;108:773-779.